Newer Birth Control Methods Linked To Blood Clot Risks

A new study released late September by the Food and Drug Administration (FDA) shows that the FDA is concerned about...
A new study released late September by the Food and Drug Administration (FDA) shows that the FDA is concerned about the potential for increased blood clot risks in women who take drospirenone-containing birth control pills. For example, the research shows that woman taking Yaz, a birth control method that contains drospirenone have a 75% greater risk of experiencing a blood clot than women taking older birth control drugs. The FDA isn't yet ready to draw an absolute conclusion regarding drospirenone-containing birth control pills, or ban them, but they are worried enough to let women know about the possible dangers. The FDA notes that women should always discuss their risk for blood clots with their medical provider, before deciding which birth control pill to use. If you smoke, are overweight, or have a family history of blood clots, you're already at an increased risk for blood clots, so this type of birth control may not be the safest choice for you. Additionally, if you're taking birth control pills, you should be aware of common symptoms of blood clots, including persistent leg pain, severe chest pain, or sudden shortness of breath. No matter what you may think is causing these symptoms, it's always wise to contact your health-care provider immediately if you're experiencing any of these symptoms. Learn more about birth control: + FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone

Tags: bleeding in women blood clots clotting healthy women reproductive health


recommended for you

Comments